ID: 2022-029 Nelfinavir Treatment of MCF-7 Breast Cancer Cells Lowers Hepcidin, Increases Ferroportin, Decreases Cellular Iron and Lowers Cell Viability: Hope to Increase Survival of Breast Cancer Patients
Reach out to us directly to learn more about this technology - Phone: (801) 422-6266